Skip to main content

Andres Juan's Form 4 filing

Moderna, Inc. (MRNA) · filed Nov 2, 2021

Accession no.
0001127602-21-028079
Filed
Nov 2, 2021
Trade date
Oct 29-Nov 1, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.40M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Andres JuanCIK 0001760670Officer (See remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 29, 2021Common StockMOption exerciseAcquired+5,000$12.21+$61,0505,000Direct
Oct 29, 2021Common StockSSaleDisposed−5,000$344.49−$1,722,4500Direct
Nov 1, 2021Common StockMOption exerciseAcquired+5,000$12.21+$61,0505,000Direct
Nov 1, 2021Common StockSSaleDisposed−5,000$335.00−$1,675,0000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 29, 2021Common StockMOption exerciseDisposed−5,000$0.00$0135,000Direct
Nov 1, 2021Common StockMOption exerciseDisposed−5,000$0.00$0130,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Chief Technical Operations and Quality Officer

Read the full filing on SEC EDGAR (opens in a new tab)